LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 55.99 | 771.67 | 1343 | 7690 | 0.1746 | 0.1818 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 55.99 | 771.67 | 1558 | 7690 | 0.2026 | 0.2359 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.21 | 771.67 | 1361 | 8085 | 0.1683 | 0.1823 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 58.21 | 771.67 | 1581 | 8085 | 0.1955 | 0.2357 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.44 | 771.67 | 1354 | 8530 | 0.1587 | 0.1761 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 60.44 | 771.67 | 1577 | 8530 | 0.1849 | 0.2290 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 62.66 | 771.67 | 1486 | 8978 | 0.1655 | 0.2033 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 62.66 | 771.67 | 1756 | 8978 | 0.1956 | 0.2614 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 64.88 | 771.67 | 1264 | 9447 | 0.1338 | 0.1463 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 64.88 | 771.67 | 1756 | 9447 | 0.1859 | 0.2555 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 67.10 | 771.67 | 1395 | 9800 | 0.1423 | 0.1752 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 67.10 | 771.67 | 1706 | 9800 | 0.1741 | 0.2416 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 69.32 | 771.67 | 1583 | 10212 | 0.1550 | 0.2127 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 69.32 | 771.67 | 1831 | 10212 | 0.1793 | 0.2610 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 71.54 | 771.67 | 1488 | 10532 | 0.1413 | 0.1902 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 71.54 | 771.67 | 1761 | 10532 | 0.1672 | 0.2446 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 73.76 | 771.67 | 1477 | 10851 | 0.1361 | 0.1856 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 73.76 | 771.67 | 1910 | 10851 | 0.1760 | 0.2683 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.02 | 771.67 | 1719 | 11106 | 0.1548 | 0.2314 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 76.02 | 771.67 | 2102 | 11106 | 0.1893 | 0.2975 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.25 | 771.67 | 1658 | 11367 | 0.1459 | 0.2178 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 78.25 | 771.67 | 2007 | 11367 | 0.1766 | 0.2793 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 80.48 | 771.67 | 1789 | 11685 | 0.1531 | 0.2392 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 80.48 | 771.67 | 2153 | 11685 | 0.1843 | 0.2992 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 82.69 | 771.67 | 1949 | 11974 | 0.1628 | 0.2639 | MN20160304_L01 | H15 |